• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Unspecified (PubMed=9274917).
  

PubMed=7506562; DOI=10.1016/0959-8049(93)90465-R
Martignone S., Menard S., Bedini A., Paccagnella A., Fasolato S., Veggian R., Colnaghi M.I.
Study of the expression and function of the tumour-associated antigen CaMBr1 in small cell lung carcinomas.
Eur. J. Cancer 29A:2020-2025(1993)

PubMed=9134423; DOI=10.1093/glycob/7.2.173
Adobati E., Panza L., Russo G., Colnaghi M.I., Canevari S.
In vitro mimicry of CaMBr1 tumor-associated antigen by synthetic oligosaccharides.
Glycobiology 7:173-178(1997)

PubMed=9274917; DOI=10.1093/jnci/89.16.1217
Arcamone F., Animati F., Berettoni M., Bigioni M., Capranico G., Casazza A.M., Caserini C., Cipollone A., De Cesare M., Franciotti M., Lombardi P., Madami A., Manzini S., Monteagudo E., Polizzi D., Pratesi G., Righetti S.C., Salvatore C., Supino R., Zunino F.
Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo.
J. Natl. Cancer Inst. 89:1217-1223(1997)